AbstractIn patients suffering from chronic hepatitis C, Interferon (INF) associated with ribavirin therapy can induce various side effects involving the skin. Our case describes the clinical course of a patient with chronic hepatitis C treated with pegylated α2 INF plus ribavirin. After 6weeks of therapy he developed psoriasis. However, given the progressive improvement of his transaminase levels and viral load decrease, we continued the protocol of the treatment and we started topical calcipotriol/betamethasone dipropionate ointment for psoriasic lesions. After this, the psoriasis improved in a slow but comprehensive manner. This paper suggests that physicians should keep in mind the possibility of the onset of psoriasis as a side effect o...
Considered more efficacious and safer than traditional systemic drugs, biologic therapies have drama...
SummaryDermatological adverse events (AEs) are an existing concern during hepatitis C virus (HCV) in...
Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infectio...
In patients suffering from chronic hepatitis C, Interferon (INF) associated with ribavirin therapy c...
Associated treatment with pegylated interferon plus specific antiviral compounds significantly impro...
ABSTRACT: This paper describes the clinical course of a patient with chronic hepatitis C, genotype 2...
We describe a patient with severe psoriasis and hepatitis C simultaneously treated with pegylated in...
Tumor necrosis factor-alpha (TNF-α) inhibitors represent an effective treatment for severe psoriasis...
The pegylated interferon-alpha (peg IFN-alpha) is one of the treatment options for chronic hepatitis...
Interferon therapy is the cornerstone of chronic hepatitis C treatment. Side effects of interferon i...
One of the most effective treatments for HCV and HBV infection is the combination of pegylated IFN-a...
Background: The interference in the immune response induced by biological disease-modifying antirheu...
Erythrodermic psoriasis is a severe and disabling variant of psoriasis. The authors present the case...
Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infectio...
Treatment of patients with psoriasis and concomitant hepatitis-C virus (HCV) infection poses a thera...
Considered more efficacious and safer than traditional systemic drugs, biologic therapies have drama...
SummaryDermatological adverse events (AEs) are an existing concern during hepatitis C virus (HCV) in...
Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infectio...
In patients suffering from chronic hepatitis C, Interferon (INF) associated with ribavirin therapy c...
Associated treatment with pegylated interferon plus specific antiviral compounds significantly impro...
ABSTRACT: This paper describes the clinical course of a patient with chronic hepatitis C, genotype 2...
We describe a patient with severe psoriasis and hepatitis C simultaneously treated with pegylated in...
Tumor necrosis factor-alpha (TNF-α) inhibitors represent an effective treatment for severe psoriasis...
The pegylated interferon-alpha (peg IFN-alpha) is one of the treatment options for chronic hepatitis...
Interferon therapy is the cornerstone of chronic hepatitis C treatment. Side effects of interferon i...
One of the most effective treatments for HCV and HBV infection is the combination of pegylated IFN-a...
Background: The interference in the immune response induced by biological disease-modifying antirheu...
Erythrodermic psoriasis is a severe and disabling variant of psoriasis. The authors present the case...
Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infectio...
Treatment of patients with psoriasis and concomitant hepatitis-C virus (HCV) infection poses a thera...
Considered more efficacious and safer than traditional systemic drugs, biologic therapies have drama...
SummaryDermatological adverse events (AEs) are an existing concern during hepatitis C virus (HCV) in...
Treatment of patients with psoriasis and/or psoriatic arthritis and concomitant hepatitis C infectio...